Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2015, Article ID 437190, 6 pages
http://dx.doi.org/10.1155/2015/437190
Research Article

Pisa Syndrome in Parkinson’s Disease: Electromyographic Aspects and Implications for Rehabilitation

1Department of Parkinson’s Disease, Movement Disorders and Brain Injury Rehabilitation, “Moriggia-Pelascini” Hospital, Gravedona ed Uniti, 22015 Como, Italy
2Department of Neurorehabilitation, “Salvatore Maugeri” Foundation, IRCCS, Scientific Institute of Pavia, via Boezio, 27100 Pavia, Italy
3Department of Biomedical Engineering, S. Maugeri Foundation, IRCCS, Scientific Institute of Montescano, 27040 Pavia, Italy
4Movement Disorders Unit, Neurological Institute, Tel Aviv Medical Centre, Sieratzki Chair of Neurology, Sackler School of Medicine, Sagol School for Neuroscience, Tel-Aviv University, 69978 Tel-Aviv, Israel

Received 7 October 2015; Accepted 9 November 2015

Academic Editor: Hélio Teive

Copyright © 2015 Giuseppe Frazzitta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Ekbom, H. Lindholm, and L. Ljungberg, “New dystonic syndrome associated with butyrophenone therapy,” Zeitschrift für Neurologie, vol. 202, no. 2, pp. 94–103, 1972. View at Publisher · View at Google Scholar · View at Scopus
  2. K. M. Doherty, B. P. van de Warrenburg, M. C. Peralta et al., “Postural deformities in Parkinson's disease,” The Lancet Neurology, vol. 10, no. 6, pp. 538–549, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Castrioto, C. Piscicelli, D. Pérennou, P. Krack, and B. Debû, “The pathogenesis of Pisa syndrome in Parkinson's disease,” Movement Disorders, vol. 29, no. 9, pp. 1100–1107, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Bonanni, A. Thomas, S. Varanese, V. Scorrano, and M. Onofrj, “Botulinum toxin treatment of lateral axial dystonia in Parkinsonism,” Movement Disorders, vol. 22, no. 14, pp. 2097–2103, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Vaugoyeau, H. Hakam, and J. P. Azulay, “Proprioceptive impairment and postural orientation in Parkinson’s disease,” Human Movement Science, vol. 30, no. 2, pp. 405–414, 2001. View at Publisher · View at Google Scholar
  6. A. Di Matteo, A. Fasano, G. Squintani et al., “Lateral trunk flexion in Parkinson's disease: EMG features disclose two different underlying pathophysiological mechanisms,” Journal of Neurology, vol. 258, no. 5, pp. 740–745, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Tinazzi, I. Juergenson, G. Squintani et al., “Pisa syndrome in Parkinson's disease: an electrophysiological and imaging study,” Journal of Neurology, vol. 260, no. 8, pp. 2138–2148, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Umemura, Y. Oka, K. Ohkita, T. Yamawaki, and K. Yamada, “Effect of subthalamic deep brain stimulation on postural abnormality in Parkinson disease: clinical article,” Journal of Neurosurgery, vol. 112, no. 6, pp. 1283–1288, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. C. Shih, V. G. Vanderhorst, A. M. Lozano, C. Hamani, and E. Moro, “Improvement of Pisa syndrome with contralateral pedunculopontine stimulation,” Movement Disorders, vol. 28, no. 4, pp. 555–556, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Ricciardi, C. Piano, A. R. Bentivoglio, and A. Fasano, “Long-term effects of pedunculopontine nucleus stimulation for Pisa syndrome,” Parkinsonism and Related Disorders, vol. 20, no. 12, pp. 1445–1446, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Tassorelli, R. De Icco, E. Alfonsi et al., “Botulinum toxin type A potentiates the effect of neuromotor rehabilitation of Pisa syndrome in Parkinson disease: a placebo controlled study,” Parkinsonism & Related Disorders, vol. 20, no. 11, pp. 1140–1144, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Dupeyron, E. Viollet, F. Coroian, C. Gagnard, D. Renard, and G. Castelnovo, “Botulinum Toxin-A for treatment of Pisa syndrome: a new target muscle,” Parkinsonism & Related Disorders, vol. 21, no. 6, pp. 669–670, 2015. View at Publisher · View at Google Scholar
  13. D. J. Gelb, E. Oliver, and S. Gilman, “Diagnostic criteria for Parkinson disease,” Archives of Neurology, vol. 56, no. 1, pp. 33–39, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Fahn and R. L. Elton, “Members of the UPDRS development committee, unified parkinson's disease rating scale,” in Recent Developments in Parkinson's Disease, S. Fahn, C. D. Marsden, D. B. Calne, and M. Goldstein, Eds., Macmillan Health Care Information, Florham Park, NJ, USA, 1987. View at Google Scholar
  15. C. Tassorelli, A. Furnari, S. Buscone et al., “Pisa syndrome in Parkinson's disease: clinical, electromyographic, and radiological characterization,” Movement Disorders, vol. 27, no. 2, pp. 227–235, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. D. A. Neumann, Ed., Kinesiology of the Musculoskeletal System. Foundations for Rehabilitation, Elsevier Health Science, 2013.
  17. S. Kakinuma, H. Nogaki, B. Pramanik, and M. Morimatsu, “Muscle weakness in Parkinson's disease: isokinetic study of the lower limbs,” European Neurology, vol. 39, no. 4, pp. 218–222, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. M. M. Catalá, D. Woitalla, and A. Arampatzis, “Central factors explain muscle weakness in young fallers with Parkinson's disease,” Neurorehabilitation and Neural Repair, vol. 27, no. 8, pp. 753–759, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. D. S. Glendinning and R. M. Enoka, “Motor unit behavior in Parkinson's disease,” Physical Therapy, vol. 74, no. 1, pp. 61–70, 1994. View at Google Scholar · View at Scopus
  20. C. Rickards and F. W. J. Cody, “Proprioceptive control of wrist movements in Parkinson's disease. Reduced muscle vibration-induced errors,” Brain, vol. 120, no. 6, pp. 977–990, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. D. H. Scocco, J. N. Wagner, J. Racosta, A. Chade, and O. S. Gershanik, “Subjective visual vertical in Pisa syndrome,” Parkinsonism & Related Disorders, vol. 20, no. 8, pp. 878–883, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Foki, W. Pirker, A. Geißler et al., “Finger dexterity deficits in Parkinson's disease and somatosensory cortical dysfunction,” Parkinsonism and Related Disorders, vol. 21, no. 3, pp. 259–265, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. A. A. Butler, S. R. Lord, M. W. Rogers, and R. C. Fitzpatrick, “Muscle weakness impairs the proprioceptive control of human standing,” Brain Research, vol. 1242, pp. 244–251, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Patel, J. Jankovic, and M. Hallett, “Sensory aspects of movement disorders,” The Lancet Neurology, vol. 13, no. 1, pp. 100–112, 2014. View at Publisher · View at Google Scholar
  25. V. Dietz, A. Gollhofer, M. Kleiber, and M. Trippel, “Regulation of bipedal stance: dependency on ‘load’ receptors,” Experimental Brain Research, vol. 89, no. 1, pp. 229–231, 1992. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Berardelli, J. C. Rothwell, P. D. Thompson, and M. Hallett, “Pathophysiology of bradykinesia in Parkinson's disease,” Brain, vol. 124, no. 11, pp. 2131–2146, 2001. View at Publisher · View at Google Scholar · View at Scopus